These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 12888801)

  • 1. GABAergic dysfunction in mood disorders.
    Brambilla P; Perez J; Barale F; Schettini G; Soares JC
    Mol Psychiatry; 2003 Aug; 8(8):721-37, 715. PubMed ID: 12888801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GABA and affective disorders.
    Lloyd KG; Morselli PL; Bartholini G
    Med Biol; 1987; 65(2-3):159-65. PubMed ID: 2821330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GABA function in mood disorders: an update and critical review.
    Shiah IS; Yatham LN
    Life Sci; 1998; 63(15):1289-303. PubMed ID: 9768867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysregulation of GABAergic neurotransmission in mood disorders: a postmortem study.
    Bielau H; Steiner J; Mawrin C; Trübner K; Brisch R; Meyer-Lotz G; Brodhun M; Dobrowolny H; Baumann B; Gos T; Bernstein HG; Bogerts B
    Ann N Y Acad Sci; 2007 Jan; 1096():157-69. PubMed ID: 17405927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance spectroscopy studies of GABA in neuropsychiatric disorders.
    Chang L; Cloak CC; Ernst T
    J Clin Psychiatry; 2003; 64 Suppl 3():7-14. PubMed ID: 12662128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma GABA in mood disorders.
    Petty F; Kramer GL; Dunnam D; Rush AJ
    Psychopharmacol Bull; 1990; 26(2):157-61. PubMed ID: 2236451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid GABA levels in chronic migraine with and without depression.
    Vieira DS; Naffah-Mazacoratti MG; Zukerman E; Senne Soares CA; Alonso EO; Faulhaber MH; Cavalheiro EA; Peres MF
    Brain Res; 2006 May; 1090(1):197-201. PubMed ID: 16638608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The emerging differential roles of GABAergic and antiglutamatergic agents in bipolar disorders.
    Ketter TA; Wang PW
    J Clin Psychiatry; 2003; 64 Suppl 3():15-20. PubMed ID: 12662129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GABA and schizophrenia: a review of basic science and clinical studies.
    Wassef A; Baker J; Kochan LD
    J Clin Psychopharmacol; 2003 Dec; 23(6):601-40. PubMed ID: 14624191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated plasma gamma-aminobutyric acid (GABA) levels in autistic youngsters: stimulus for a GABA hypothesis of autism.
    Dhossche D; Applegate H; Abraham A; Maertens P; Bland L; Bencsath A; Martinez J
    Med Sci Monit; 2002 Aug; 8(8):PR1-6. PubMed ID: 12165753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular levels of serotonin and GABA in the hippocampus after chronic mild stress in rats. A microdialysis study in an animal model of depression.
    Grønli J; Fiske E; Murison R; Bjorvatn B; Sørensen E; Ursin R; Portas CM
    Behav Brain Res; 2007 Jul; 181(1):42-51. PubMed ID: 17477980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability of plasma GABA at four-year follow-up in patients with primary unipolar depression.
    Petty F; Kramer GL; Fulton M; Davis L; Rush AJ
    Biol Psychiatry; 1995 Jun; 37(11):806-10. PubMed ID: 7647165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neuropsychiatric disorders and GABA].
    Fujimori S; Yoneda Y
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2004 Oct; 24(5):265-71. PubMed ID: 15658502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Classifying mood disorders by age-at-onset instead of polarity.
    Benazzi F
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):86-93. PubMed ID: 18992784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critical role of brain-derived neurotrophic factor in mood disorders.
    Hashimoto K; Shimizu E; Iyo M
    Brain Res Brain Res Rev; 2004 May; 45(2):104-14. PubMed ID: 15145621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [GABA and mood disorders].
    Waintraub L
    Encephale; 1987 Jul; 13 Spec No():203-8. PubMed ID: 3319525
    [No Abstract]   [Full Text] [Related]  

  • 17. Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments.
    Krystal JH; Sanacora G; Blumberg H; Anand A; Charney DS; Marek G; Epperson CN; Goddard A; Mason GF
    Mol Psychiatry; 2002; 7 Suppl 1():S71-80. PubMed ID: 11986998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GABA, gamma-hydroxybutyric acid, and neurological disease.
    Wong CG; Bottiglieri T; Snead OC
    Ann Neurol; 2003; 54 Suppl 6():S3-12. PubMed ID: 12891648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance spectroscopy: neurochemistry and treatment effects in affective disorders.
    Moore GJ; Galloway MP
    Psychopharmacol Bull; 2002; 36(2):5-23. PubMed ID: 12397837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo evidence for reduced cortical glutamate-glutamine cycling in rats treated with the antidepressant/antipanic drug phenelzine.
    Yang J; Shen J
    Neuroscience; 2005; 135(3):927-37. PubMed ID: 16154287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.